Please select one: * I am in active clinical practice I am retired I am a student Other Please score your agreement with or assessment of the following questions and statements by rating on a scale of 1 to 5, with 5 representing the highest level of satisfaction or agreement. * Scoring Key: 5=Strongly Agree 4=Agree 3=Neutral 2=Disagree 1=Strongly Disagree 54321 54321 The information and/or skills learned will enhance my professional competence or ability. The information and/or skills learned will enhance my professional competence or ability. - 5 The information and/or skills learned will enhance my professional competence or ability. - 4 The information and/or skills learned will enhance my professional competence or ability. - 3 The information and/or skills learned will enhance my professional competence or ability. - 2 The information and/or skills learned will enhance my professional competence or ability. - 1 This activity conveyed information which will assist me in improving the health and/or treatment outcomes of of my patients. This activity conveyed information which will assist me in improving the health and/or treatment outcomes of of my patients. - 5 This activity conveyed information which will assist me in improving the health and/or treatment outcomes of of my patients. - 4 This activity conveyed information which will assist me in improving the health and/or treatment outcomes of of my patients. - 3 This activity conveyed information which will assist me in improving the health and/or treatment outcomes of of my patients. - 2 This activity conveyed information which will assist me in improving the health and/or treatment outcomes of of my patients. - 1 How confident are you in your ability to: * 5 = High level of confidence 4 = Moderately high level of confidence 3 = Average level of confidence 2 = Low level of confidence 1 = No level of confidence Not applicable|Not applicable 54321Not applicable 54321Not applicable Assess recent advances in clinical medicine and related sciences in light of the supporting evidence. Assess recent advances in clinical medicine and related sciences in light of the supporting evidence. - 5 Assess recent advances in clinical medicine and related sciences in light of the supporting evidence. - 4 Assess recent advances in clinical medicine and related sciences in light of the supporting evidence. - 3 Assess recent advances in clinical medicine and related sciences in light of the supporting evidence. - 2 Assess recent advances in clinical medicine and related sciences in light of the supporting evidence. - 1 Assess recent advances in clinical medicine and related sciences in light of the supporting evidence. - Not applicable Apply updated knowledge of internal medicine to clinical practice to improve patient care. Apply updated knowledge of internal medicine to clinical practice to improve patient care. - 5 Apply updated knowledge of internal medicine to clinical practice to improve patient care. - 4 Apply updated knowledge of internal medicine to clinical practice to improve patient care. - 3 Apply updated knowledge of internal medicine to clinical practice to improve patient care. - 2 Apply updated knowledge of internal medicine to clinical practice to improve patient care. - 1 Apply updated knowledge of internal medicine to clinical practice to improve patient care. - Not applicable Outline the clinical implications of recent research in selected areas of internal medicine. Outline the clinical implications of recent research in selected areas of internal medicine. - 5 Outline the clinical implications of recent research in selected areas of internal medicine. - 4 Outline the clinical implications of recent research in selected areas of internal medicine. - 3 Outline the clinical implications of recent research in selected areas of internal medicine. - 2 Outline the clinical implications of recent research in selected areas of internal medicine. - 1 Outline the clinical implications of recent research in selected areas of internal medicine. - Not applicable Evaluate and respond to changes in the external practice environment and their potential impact on medical practice and patient care. Evaluate and respond to changes in the external practice environment and their potential impact on medical practice and patient care. - 5 Evaluate and respond to changes in the external practice environment and their potential impact on medical practice and patient care. - 4 Evaluate and respond to changes in the external practice environment and their potential impact on medical practice and patient care. - 3 Evaluate and respond to changes in the external practice environment and their potential impact on medical practice and patient care. - 2 Evaluate and respond to changes in the external practice environment and their potential impact on medical practice and patient care. - 1 Evaluate and respond to changes in the external practice environment and their potential impact on medical practice and patient care. - Not applicable Improve clinical practice by incorporating major new developments in subspecialty medicine. Improve clinical practice by incorporating major new developments in subspecialty medicine. - 5 Improve clinical practice by incorporating major new developments in subspecialty medicine. - 4 Improve clinical practice by incorporating major new developments in subspecialty medicine. - 3 Improve clinical practice by incorporating major new developments in subspecialty medicine. - 2 Improve clinical practice by incorporating major new developments in subspecialty medicine. - 1 Improve clinical practice by incorporating major new developments in subspecialty medicine. - Not applicable How satisfied or dissatisfied were you with the Speaker's effectiveness in addressing the learning objectives? * Scoring Key: 5=Strongly satisfied 4= Somewhat satisfied 3=Neither satisfied nor dissatisfied 2= Somewhat dissatisfied 1=Strongly dissatisfied NA= Not Applicable 54321NA 54321NA KEYNOTE LECTURE: Climate Change and Health - Arianne Teherani, Ph.D. and Sheri Weiser, M.D., M.A., MPH KEYNOTE LECTURE: Climate Change and Health - Arianne Teherani, Ph.D. and Sheri Weiser, M.D., M.A., MPH - 5 KEYNOTE LECTURE: Climate Change and Health - Arianne Teherani, Ph.D. and Sheri Weiser, M.D., M.A., MPH - 4 KEYNOTE LECTURE: Climate Change and Health - Arianne Teherani, Ph.D. and Sheri Weiser, M.D., M.A., MPH - 3 KEYNOTE LECTURE: Climate Change and Health - Arianne Teherani, Ph.D. and Sheri Weiser, M.D., M.A., MPH - 2 KEYNOTE LECTURE: Climate Change and Health - Arianne Teherani, Ph.D. and Sheri Weiser, M.D., M.A., MPH - 1 KEYNOTE LECTURE: Climate Change and Health - Arianne Teherani, Ph.D. and Sheri Weiser, M.D., M.A., MPH - NA Current Approach to Asthma Evaluation and Management - Margaret M. Johnson, M.D. Current Approach to Asthma Evaluation and Management - Margaret M. Johnson, M.D. - 5 Current Approach to Asthma Evaluation and Management - Margaret M. Johnson, M.D. - 4 Current Approach to Asthma Evaluation and Management - Margaret M. Johnson, M.D. - 3 Current Approach to Asthma Evaluation and Management - Margaret M. Johnson, M.D. - 2 Current Approach to Asthma Evaluation and Management - Margaret M. Johnson, M.D. - 1 Current Approach to Asthma Evaluation and Management - Margaret M. Johnson, M.D. - NA When are Steroids Indicated in Community Acquired Pneumonia - Margaret M. Johnson, M.D. When are Steroids Indicated in Community Acquired Pneumonia - Margaret M. Johnson, M.D. - 5 When are Steroids Indicated in Community Acquired Pneumonia - Margaret M. Johnson, M.D. - 4 When are Steroids Indicated in Community Acquired Pneumonia - Margaret M. Johnson, M.D. - 3 When are Steroids Indicated in Community Acquired Pneumonia - Margaret M. Johnson, M.D. - 2 When are Steroids Indicated in Community Acquired Pneumonia - Margaret M. Johnson, M.D. - 1 When are Steroids Indicated in Community Acquired Pneumonia - Margaret M. Johnson, M.D. - NA Novel Lipid-Lowering therapies - from PROMINENT to HORIZON - Michael J. Blaha, M.D., MPH Novel Lipid-Lowering therapies - from PROMINENT to HORIZON - Michael J. Blaha, M.D., MPH - 5 Novel Lipid-Lowering therapies - from PROMINENT to HORIZON - Michael J. Blaha, M.D., MPH - 4 Novel Lipid-Lowering therapies - from PROMINENT to HORIZON - Michael J. Blaha, M.D., MPH - 3 Novel Lipid-Lowering therapies - from PROMINENT to HORIZON - Michael J. Blaha, M.D., MPH - 2 Novel Lipid-Lowering therapies - from PROMINENT to HORIZON - Michael J. Blaha, M.D., MPH - 1 Novel Lipid-Lowering therapies - from PROMINENT to HORIZON - Michael J. Blaha, M.D., MPH - NA The Role of DOACS in Stable Coronary Disease - Pragnesh P. Parikh, M.D. The Role of DOACS in Stable Coronary Disease - Pragnesh P. Parikh, M.D. - 5 The Role of DOACS in Stable Coronary Disease - Pragnesh P. Parikh, M.D. - 4 The Role of DOACS in Stable Coronary Disease - Pragnesh P. Parikh, M.D. - 3 The Role of DOACS in Stable Coronary Disease - Pragnesh P. Parikh, M.D. - 2 The Role of DOACS in Stable Coronary Disease - Pragnesh P. Parikh, M.D. - 1 The Role of DOACS in Stable Coronary Disease - Pragnesh P. Parikh, M.D. - NA Beyond AFFIRM: Contemporary Management of Atrial Fibrillation - Louis H. Miller, M.D., FACC FACP Beyond AFFIRM: Contemporary Management of Atrial Fibrillation - Louis H. Miller, M.D., FACC FACP - 5 Beyond AFFIRM: Contemporary Management of Atrial Fibrillation - Louis H. Miller, M.D., FACC FACP - 4 Beyond AFFIRM: Contemporary Management of Atrial Fibrillation - Louis H. Miller, M.D., FACC FACP - 3 Beyond AFFIRM: Contemporary Management of Atrial Fibrillation - Louis H. Miller, M.D., FACC FACP - 2 Beyond AFFIRM: Contemporary Management of Atrial Fibrillation - Louis H. Miller, M.D., FACC FACP - 1 Beyond AFFIRM: Contemporary Management of Atrial Fibrillation - Louis H. Miller, M.D., FACC FACP - NA Osteoporosis and Other Metabolic Bone Diseases - John P. Bilezikian, M.D., Ph.D. (hon) Osteoporosis and Other Metabolic Bone Diseases - John P. Bilezikian, M.D., Ph.D. (hon) - 5 Osteoporosis and Other Metabolic Bone Diseases - John P. Bilezikian, M.D., Ph.D. (hon) - 4 Osteoporosis and Other Metabolic Bone Diseases - John P. Bilezikian, M.D., Ph.D. (hon) - 3 Osteoporosis and Other Metabolic Bone Diseases - John P. Bilezikian, M.D., Ph.D. (hon) - 2 Osteoporosis and Other Metabolic Bone Diseases - John P. Bilezikian, M.D., Ph.D. (hon) - 1 Osteoporosis and Other Metabolic Bone Diseases - John P. Bilezikian, M.D., Ph.D. (hon) - NA Was this course fair, balanced and without commercial bias? * Yes No If you checked "No,” please explain why: * As a result of my participation in this Symposium, I commit to make the following changes to my clinical practice: * I will discuss the diagnosis, evaluation, and therapeutic concepts of major metabolic bone diseases such as osteoporosis and the parathyroid disorders. I will discuss the impact of systemic steroid therapy on clinical outcomes in patients with community acquired pneumonia (CAP). I will describe an approach for selecting first-line pharmacological antiarrhythmic agents in atrial fibrillation treatment, considering patient-specific factors. I will elucidate implications of the PROMINENT and HORIZON trials. Not applicable to my practice. I do not agree with the recommendations presented. I am retired. How many patients will you see in your practice who will likely be impacted by what you learned at this activity? * 1-5 6-10 11-15 Over 15 NA What, if any, new skills/strategies will you apply in your clinical practice? * What are the potential barriers or obstacles that might prevent you from implementing new strategies you learned at this activity? * Comments Please select one: * M.D., D.O. Ph.D. Psy.D. DPM PA-C ARNP R.N. Pharmacist Other... Please select one: Other... Name Attestation * Choose 1 option I attest that I have participated in this live virtual symposium in its entirety. I attest that I have participated in _____ hours of instruction during this live webinar. hours attestation * Hours attended (Max 4.5 hrs.) Leave this field blank